C07D 261/16
Benzene-sulfonamido isoxazoles
C07D261/16 (Benzene-sulfonamido isoxazoles) appears on 95 US grants and 84 published applications in this corpus.
Search patents in C07D- Granted patents
- 95
- Published applications
- 84
- Assignees
- 63
- Inventors
- 269
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 3 |
| 2002 | 6 | 6 |
| 2003 | 6 | 6 |
| 2004 | 7 | 10 |
| 2005 | 2 | 3 |
| 2006 | 2 | 2 |
| 2007 | 2 | 2 |
| 2008 | 1 | 1 |
| 2009 | 2 | 2 |
| 2010 | 1 | 2 |
| 2011 | 2 | 3 |
| 2012 | 5 | 3 |
| 2013 | 3 | 3 |
| 2014 | 3 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 4 |
| 2017 | 3 | 4 |
| 2018 | 3 | 4 |
| 2019 | 5 | 4 |
| 2020 | 5 | 5 |
| 2021 | 1 | 3 |
| 2022 | 2 | 2 |
| 2023 | 1 | 3 |
| 2024 | 1 | 3 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Platform drug delivery system utilizing crystal engineering and theanine dissolution8 Apr 2025US 12,268,783 B2Theaprin Pharmaceuticals Inc.
- Compounds27 Feb 2024US 11,911,372 B2Ctxt Pty Ltd
- USP30 inhibitors and uses thereof19 Dec 2023US 11,845,724 B2Vincere Biosciences, Inc.
- Benzenesulfonamide compounds and their use as therapeutic agents12 Apr 2022US 11,299,490 B2Xenon Pharmaceuticals Inc.
- Catalytic inhibitor of protein phosphatase 5 activates the extrinsic apoptotic pathway by disrupting complex ii27 Nov 2025US 2025/0360108 A1The Research Foundation for The State University of New York
- Platform drug delivery system utilizing crystal engineering and theanine dissolution17 Jul 2025US 2025/0228778 A1Theaprin Pharmaceuticals Inc.
- Compounds22 Aug 2024US 2024/0277683 A1Ctxt Pty Ltd
- Usp30 inhibitors and uses thereof8 Aug 2024US 2024/0262792 A1Vincere Biosciences, Inc.
- Modulators of fpr1 and methods of using the same18 Jan 2024US 2024/0018124 A1Biofront Ltd
Most cited
By later US patents
- Substituted biphenyl isoxazole sulfonamides222US 5,612,359 ABristol-Myers Squibb Company · 1997
- N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin97US 5,514,691 AImmunopharmaceutics, Inc. · 1996
- Sulfonamides and derivatives thereof that modulate the activity of endothelin91US 5,571,821 ATexas Biotechnology Corporation · 1996
- N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin69US 5,464,853 AImmunopharmaceutics, Inc. · 1995
- Isoxazoline-substituted benzamide compound and pesticide69US 7,662,972 B2Nissan Chemical Industries, Ltd. · 2010